IP Library › Assignment 035279/0990
Patent Assignment
Reel/Frame 035279/0990

Assignment of Assignor's Interest

Recorded: 2015-03-27 Pages: 6
Assignor
ZACHARON PHARMACEUTICALS, INC.
Executed: 2013-04-01
Assignee
BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE, NOVATO, CALIFORNIA, 94949
Covered Property (1)
Quantification of Non-Reducing End Glycan Residual Compounds for Determining the Presence, Identity, or Severity of a Disease or Condition
Patent: 9,222,120 →
Application: 14/321,413 →
Publication: US 2014/0308684
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 27, 2015
From: CRAWFORD, BRETT E; BROWN, JILLIAN R; GLASS, CHARLES A; BEITEL, JIM E
To: ZACHARON PHARMACEUTICALS, INC.
Reel/Frame 035280/0001 →
Corrective Assignment to Correct the First Conveying Party's Name Previously Recorded at Reel: 035280 Frame: 0001. Assignor(S) Hereby Confirms the Assignment. Mar 30, 2015
From: CRAWFORD, BRETT E; BROWN, JILLIAN R; GLASS, CHARLES A; BEITEL, JIM R
To: ZACHARON PHARMACEUTICALS, INC.
Reel/Frame 035336/0879 →
Assignment of Assignor's Interest Jun 14, 2016
From: CRAWFORD, BRETT E.; BROWN, JILLIAN R.; GLASS, CHARLES A.; BEITEL, JIM R.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 038908/0146 →
Security Interest Apr 27, 2026
From: BIOMARIN PHARMACEUTICAL INC.; AMICUS THERAPEUTICS, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075493/0968 →